Dose-Finding Designs for Early-Phase Cancer Clinical Trials

Takashi Daimon

ISBN 10: 4431555846 / ISBN 13: 9784431555841

Published by Springer Japan Mai 2019, 2019

About this Item

This item is printed on demand - it takes 3-4 days longer - Neuware -This book provides a comprehensive introduction to statistical methods for designing early phase dose-finding clinical trials. It will serve as a textbook or handbook for graduate students and practitioners in biostatistics and clinical investigators who are involved in designing, conducting, monitoring, and analyzing dose-finding trials. The book will also provide an overview of advanced topics and discussions in this field for the benefit of researchers in biostatistics and statistical science. Beginning with backgrounds and fundamental notions on dose finding in early phase clinical trials, the book then provides traditional and recent dose-finding designs of phase I trials for, e.g., cytotoxic agents in oncology, to evaluate toxicity outcome. Included are rule-based and model-based designs, such as 3 + 3 designs, accelerated titration designs, toxicity probability interval designs, continual reassessment method and related designs, and escalation overdose control designs. This bookalso covers more complex and updated dose-finding designs of phase I-II and I/II trials for cytotoxic agents, and cytostatic agents, focusing on both toxicity and efficacy outcomes, such as designs with covariates and drug combinations, maximum tolerated dose-schedule finding designs, and so on. 152 pp. Englisch.

Seller Inventory # 9784431555841

Bibliographic Details

• Title: Dose-Finding Designs for Early-Phase Cancer Clinical Trials
• Publisher: Springer Japan Mai 2019
• Publication Date: 2019
• Language: English
• ISBN 10: 4431555846
• ISBN 13: 9784431555841
• Binding: Taschenbuch
• Condition: Neu
• Dimensions: 235W x 155H x 9D millimeters 235 millimeters width by 155 millimeters height by 9 millimeters depth
• Weight: 242 grams

About this title

Synopsis

This book provides a comprehensive introduction to statistical methods for designing early phase dose-finding clinical trials. It will serve as a textbook or handbook for graduate students and practitioners in biostatistics and clinical investigators who are involved in designing, conducting, monitoring, and analyzing dose-finding trials. The book will also provide an overview of advanced topics and discussions in this field for the benefit of researchers in biostatistics and statistical science. Beginning with backgrounds and fundamental notions on dose finding in early phase clinical trials, the book then provides traditional and recent dose-finding designs of phase I trials for, e.g., cytotoxic agents in oncology, to evaluate toxicity outcome. Included are rule-based and model-based designs, such as 3 + 3 designs, accelerated titration designs, toxicity probability interval designs, continual reassessment method and related designs, and escalation overdose control designs. This bookalso covers more complex and updated dose-finding designs of phase I-II and I/II trials for cytotoxic agents, and cytostatic agents, focusing on both toxicity and efficacy outcomes, such as designs with covariates and drug combinations, maximum tolerated dose-schedule finding designs, and so on.

About the Author

Takashi Daimon, Department of Biostatistics, Hyogo College of Medicine

Akihiro Hirakawa, Center for Advanced Medicine and Clinical Research, Nagoya University Graduate School of Medicine

Shigeyuki Matsui, Department of Biostatistics, Nagoya University Graduate School of Medicine